Paramit Expands Product Development Services

Posted August 25th, 2022

Tecan Systems

Paramit Corporation, a contract manufacturer of medical devices and diagnostic instruments, continues to offer product development services using Tecan’s 300+ person R&D team.

Tecan acquired Paramit in 2021 to expand its vision of scaling healthcare innovation globally.  In addition to Tecan’s Bay Area R&D resources, Paramit leverages a Switzerland based team which has deep talent in software development, systems engineering, and V&V testing.  From planning and conceptualization to design, manufacturing, and even post-production service, Paramit is positioned to successfully serve OEM’s design and manufacturing needs.

Based in Morgan Hill and less than a mile from Paramit’s manufacturing facility, Tecan Systems R&D has design expertise with optics, fluidics, motion control, and industrial design.  Close proximity between design and manufacturing teams helps promote a long-term success mindset, where scalability and production costs are not ignored.

About Paramit

Paramit is an FDA-registered manufacturer of medical devices and life science instruments.  With operations in the U.S., Europe, and Malaysia, Paramit offers OEMs a low risk approach to designing, assembling, and testing mechatronic intensive devices such as point-of-use medical equipment and benchtop laboratory instruments.  Paramit’s vPoke® computer directed assembly process provides a zero-defect manufacturing environment in ISO 13485 certified facilities.

For more information, please visit

About Tecan

Tecan helps to improve people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,000 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2021, Tecan generated sales of CHF 947 million (USD 1,041 million; EUR 877 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For more information, please visit